Exposure to hardly soluble indium compounds in ITO production and recycling plants is a new risk for interstitial lung damage

Occupational and Environmental Medicine

Volumn 65, Issue 1, 2008, Pages 51-55

  Hamaguchi, T ^a,d   Omae, K ^a   Takebayashi, T ^a   Kikuchi, Y ^a   Yoshioka, N ^a   Nishiwaki, Y ^a   Tanaka, A ^b   Hirata, M ^b   Taguchi, O ^c   Chonan, T ^c  

^a KEIO UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c Nikko Memorial Hospital   (Japan)

^d NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INDIUM;

ADULT; ARTICLE; CONTROLLED STUDY; GEOMETRY; HEALTH HAZARD; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RECYCLING; REFERENCE VALUE; SPIROMETRY;

ADULT; AGED; CONSERVATION OF NATURAL RESOURCES; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DUST; HUMANS; INDIUM; JAPAN; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PHOSPHINES; SMOKING; SOLUBILITY; SPIROMETRY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 38049170541     PISSN: 13510711     EISSN: None     Source Type: Journal    
DOI: 10.1136/oem.2006.029124     Document Type: Article

References (24)

1. Kabe I, Omae K, Nakashima H, et al. In vitro solubility and in vivo toxicity of indium phosphide. J Occup Health 1996;38:6-12.
2. Oda K. Toxicity of a low level of indium phosphide (InP) in rats after intratracheal instillation. Indust Health 1997;35:61-8.
3. Uemura T, Oda K, Omae K, et al. Effects of intratracheally administered indium phosphide on male Fischer 344 rats. J Occup Health 1997;39:205-10.
4. Tanaka A, Hisanaga A, Hirata M, et al. Chronic toxicity of indium arsenide and indium phosphide to the lung of hamsters. Fukuoka Acta Med 1996;87:108-15.
5. Tanaka A, Hirata M, Omura M, et al. Comparative study of the toxic effects of gallium arsenide, indium arsenide and arsenic trioxide following intratracheal instillations to the lung of Syrian golden hamsters. Fukuoka Acta Med 2000;91:21-33.
6. Yamazaki K, Tanaka A, Hirata M, et al. Long term pulmonary toxicity of indium arsenide and indium phosphide instilled intratracheally in hamsters. J Occup Health 2002;42:169-78
7. Omura M, Tanaka A, Hirata M, et al. Testicular toxicity of gallium arsenide, indium arsenide, and arsenic oxide in rats by repetitive intratracheal instillation. Fundam Appl Toxicol 1996;32:72-78.
8. Omura M, Yamazaki K, Tanaka A, et al. Changes in the testicular damage caused by indium arsenide and indium phosphide in hamsters during two years after intratracheal instillations. J Occup Health 2000;42:196-204.
9. National Toxicology Program. Toxicology and carcinogenesis studies of indium phosphide (CAS No 22398-80-7) in F344/N rats and BBC3F1 mice (Inhalation studies). Bethesda, MD: US Department of Health and Human Service, Public Health Service, 2001.
10. IARC. Monographs Vol 86. Cobalt in hard metals and cobalt sulfate, gallium arsenide, indium phosphide and vanadium pentoxide. Lyon, France: International Agency for Research on Cancer, 2006.
11. Homma T, Ueno T, Sekizawa K, et al. Interstitial pneumonia developed in a worker dealing with dusts containing indium-tin oxide. J Occup Health 2003;45:137-9
12. Homma S, Miyamoto A, Sakamoto S, et al. Pulmonary fibrosis in an individual occupationally exposed to inhaled indium-tin oxide. Eur Respir J 2005;25:200-4.
13. Chonan T, Taguchi O, Omae K. Interstitial pulmonary disease in indium-processing workers. Eur Respir J 2007;29:317-24.
14. Miyaki K, Hosoda K, Hirata M, et al. Biological monitoring of indium using graphite furnace atomic absorption spectrophotometry in workers exposed to particles of indium compounds. J Occup Health 2003;45:228-30.
15. The Japanese Respiratory Society. Guidelines for respiratory function tests - spirometry, flow-volume curve, diffusing capacity of the lung [in Japanese]. Tokyo, Japan: Medical Review Co Ltd, 2004.
16. The Japanese Respiratory Society. Guidelines for the diagnosis and management of COPD [in Japanese]. Tokyo, Japan: Medical Review Co Ltd, 2001.
17. Hermans C, Bernard A. State of the art: lung epithelium-specific proteins. Characteristics and potential applications as markers. Am J Respir Crit Care Med 1999;159:646-78.
18. Kohno N, Kyoizumi S, Awaya Y, et al. New serum indicator of interstitial pneumonitis activity: sialylated carbohydrate antigen KL-6. Chest 1989;96:68-73.
19. Hisayama Y, KornoN, Yokoyama A, et al. KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts. Am J Respir Cell Mol Biol 1997;17:501-7.
20. Yokoyama A, Kohno N, Hamada H, et al. Circulating KL-6 predict the outcome of rapidly progressive idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998;158:1680-4.
21. Kohno N. Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis. J Medical Invest 1999;46:151-8.
22. Ohnishi H, Yokoyama A, Kondo K, et al. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am J Respir Crit Care Med 2002;165:378-81.
23. Stewart JH, Lassiter DV. Germanium, tin, and copper. In: Bingham ER, Cohrssen B, Powell CH, eds. Patty's toxicology. Fifth edition. John Wiley & Sons, Inc, 2001;2:585.
24. Sluis-Cremer GK, Thomas RG, Goldstein B, et al. Stannosis. A report of 2 cases. S Afr Med J 1989;75:124-6.